A phase II, open-label study of ONC201 in adults with recurrent high-grade glioma
|Effective start/end date||3/12/19 → 3/30/24|
- ONCOCEUTICS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.